![tert-Butyl (4R,6R)-2-[[[6-(2-4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetate structure, CAS 125971-95-1](/structures/60000/51710_1_125971_95_1.png)
CAS Number125971-95-1
SynonymsAtorvastatin Acetonide tert-Butyl Ester; MFCD08458280; Atorvastatin intermediate L1; Atorvastatin calciuM interMediate
Molecular FormulaC40H47FN2O5
Molecular Weight654.81
Purity98.00%
Density1.1±0.1 g/cm3
Boiling Point678.0±55.0 °C at 760 mmHg
Melting Point144-148 °C (lit.)
AppearanceSolid;White to Almost white powder to crystal
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 125971-95-1 |
| Catalog No. | 2A-9051710 |
| Chinese Name | (4R,6R)-2-[6-[2-[2-(4-氟苯基)-5-异丙酯-3-苯基-4-(苯基氨甲酰基)吡咯-1-基]乙基]-2,2-二甲基-1,3-二恶烷-4-基]醋酸叔丁酯 |
| Synonyms | Atorvastatin Acetonide tert-Butyl Ester; MFCD08458280; Atorvastatin intermediate L1; Atorvastatin calciuM interMediate |
| Molecular Formula | C40H47FN2O5 |
| Molecular Weight | 654.81 |
| Purity | 98.00 |
| Density | 1.1±0.1 g/cm3 |
| Boiling Point | 678.0±55.0 °C at 760 mmHg |
| Melting Point | 144-148 °C (lit.) |
| Appearance | Solid;White to Almost white powder to crystal |
| Water Solubility | Soluble in: chloroform |
| Storage Condition | room temperature |
| Application | Atorvastatin acetonide tert-butyl ester is a useful intermediate for the preparation of Atorvastatin salts. Atorvastatin is an oral HMG-CoA reductase inhibitor that can effectively lower blood lipids. |
| PubChem ID | 329749080 |
| MDL Number | MFCD04039904 |
| SMILES | CC(C)c1c(C(=O)Nc2ccccc2)c(-c3ccccc3)c(-c4ccc(F)cc4)n1CC[C@@H]5C[C@H](CC(=O)OC(C)(C)C)OC(C)(C)O5 |
| InChI | 1S/C40H47FN2O5/c1-26(2)36-35(38(45)42-30-16-12-9-13-17-30)34(27-14-10-8-11-15-27)37(28-18-20-29(41)21-19-28)43(36)23-22-31-24-32(47-40(6,7)46-31)25-33(44)48-39(3,4)5/h8-21,26,31-32H,22-25H2,1-7H3,(H,42,45)/t31-,32-/m1/s1 |
| InChI Key | NPPZOMYSGNZDKY-ROJLCIKYSA-N |
| NACRES Code | NA.24 |
| UNSPSC | 41116107 |
| Hazard Symbols | transportation |
| MSDS | msds/51710_1_125971_95_1.pdf |
| Bioactivity | Atorvastatin acetonide tert-butyl ester is a useful pharmaceutical intermediate in the preparation of Atorvastatin salts. Atorvastatin is an orally active HMG-CoA reductase inhibitor and has the ability to effectively decrease blood lipids[1]. Related Catalog Research Areas >> Others Signaling Pathways >> Others >> Others References [1]. Process for preparing amorphous (4r-cis)-6-[2-[3-phenyl-4-(phenylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methylethyl)-pyrrol-1-yl]-ethyl]-2,2-dimethyl-[1,3]-dioxane-4-yl-acetic acid. WO2005063741A1. Chemical & Physical Properties Density 1.1±0.1 g/cm3 Boiling Point 678.0±55.0 °C at 760 mmHg Melting Point 144-148ºC Molecular Formula C40H47FN2O5 Molecular Weight 654.810 Flash Point 363.9±31.5 °C Exact Mass 654.346924 PSA 78.79000 LogP 7.78 Vapour Pressure 0.0±2.1 mmHg at 25°C Index of Refraction 1.569 |
| Use of | Atorvastatin acetonide tert-butyl ester is a useful pharmaceutical intermediate in the preparation of Atorvastatin salts. Atorvastatin is an orally active HMG-CoA reductase inhibitor and has the ability to effectively decrease blood lipids[1]. Properties Name tert-Butyl (4R,6R)-2-[[[6-(2-4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetate Synonym More Synonyms Atorvastatin Acetonide tert-Butyl Ester Biological Activity Description Atorvastatin acetonide tert-butyl ester is a useful pharmaceutical intermediate in the preparation of Atorvastatin salts. Atorvastatin is an orally active HMG-CoA reductase inhibitor and has the ability to effectively decrease blood lipids[1]. Related Catalog Research Areas >> Others Signaling Pathways >> Others >> Others References [1]. Process for preparing amorphous (4r-cis)-6-[2-[3-phenyl-4-(phenylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methylethyl)-pyrrol-1-yl]-ethyl]-2,2-dimethyl-[1,3]-dioxane-4-yl-acetic acid. WO2005063741A1. Chemical & Physical Properties Molecular Formula C40H47FN2O5 Exact Mass 654.346924 PSA 78.79000 Index of Refraction 1.569 |
| Transport Info | Shipping Name: UN |
| MSDS Transport Info | Module 14. Shipping information 14.1 United Nations number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 United Nations shipping name European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Danger Regulations: No International Maritime Danger Regulations International Air Transport Danger Regulations: No Marine pollutants (yes/no): No 14.6 Special precautions No data available |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| Methyl 3-(methoxycarbonyl)-7-oxo-9-azabicyclo[3.3.1]nonane-9-acetate | 125483-28-5 | 2A-9051681 |
| 1-N-Boc-4-(Phenylamino)piperidine | 125541-22-2 | 2A-9051682 |
| (R)-5,6,7,8-Tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthalenol hydrochloride | 125572-92-1 | 2A-9051685 |
| (S)-1-(3-Nitrophenyl)propanol | 125712-82-5 | 2A-9051699 |
| (4R,6R)-tert-Butyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate | 125971-94-0 | 2A-9051709 |
| 2-(Trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine | 126069-70-3 | 2A-9051719 |
| Methyl 4-amino-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylate | 126149-77-7 | 2A-9051722 |
| (S)-2',6'-Dimethyltyrosine hydrochloride | 126312-63-8 | 2A-9051733 |
| (S)-1-tert-Butyl 2-methyl aziridine-1,2-dicarboxylate | 126496-79-5 | 2A-9051743 |
| (R)-2-Chloro-1-(4-fluorophenyl)ethanol | 126534-43-8 | 2A-9051745 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA